GERN
GERON CORP
NASDAQ · Healthcare · Biotechnology · US
$1.30
−1.52%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.01
- Revenue estimate
- $60.6M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$0.01
- Revenue actual
- $57.5M
- Revenue estimate
- $56.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -26.8%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.01 | -$0.02 | Miss -125.23% | $57.5M |
| May 6, 2026 | -$0.03 | -$0.01 | Beat 66.67% | $51.8M |
| Feb 25, 2026 | -$0.03 | -$0.05 | Miss -66.67% | $48.0M |
| Nov 5, 2025 | -$0.04 | -$0.03 | Beat 18.19% | $47.2M |
| Aug 6, 2025 | -$0.03 | -$0.02 | Beat 33.33% | $49.0M |
| May 7, 2025 | -$0.04 | -$0.03 | Beat 25.00% | $39.6M |
| Feb 26, 2025 | -$0.04 | -$0.04 | In line | $47.5M |
| Nov 7, 2024 | -$0.09 | -$0.04 | Beat 55.56% | $28.3M |
| Aug 8, 2024 | -$0.11 | -$0.10 | Beat 9.09% | $882.0K |
| May 2, 2024 | -$0.10 | -$0.09 | Beat 10.00% | $304.0K |
| Feb 28, 2024 | -$0.10 | -$0.09 | Beat 10.00% | $23.0K |
| Nov 2, 2023 | -$0.10 | -$0.08 | Beat 20.00% | $164.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026